Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

THE Beautiful AND THE Damned

Newsweek Europe

|

May 09, 2025

How GLP-1 drugs like MOUNJARO and OZEMPIC are redefining the debate about size, weight loss and PRIVILEGE

- by JESUS MESA

THE Beautiful AND THE Damned

SAMHITA MUKHOPADHYAY WASN'T expecting shame to come from a photo. The longtime feminist writer and former Teen Vogue editor had just moderated a panel at a media conference. She was dressed in a skirt and printed top she felt good in—until she saw a candid image someone had posted online. “It was devastating,” she told Newsweek. Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, sleeping more soundly and even considering a wardrobe overhaul. But the cost of the drug forced her to stop. “I knew better,” she said. “As a feminist writer and committed proponent of body positivity, I'd spent years trying to love my body at any size. And yet, here I was, agonizing over a picture of myself.

That contradiction, she said, was the real heartbreak—not just for her, but for the women who long-embraced the body positivity messaging themselves. “Taking something for weight loss made me feel like I was being vain, that I didn’t have the willpower to lose weight, eat better or exercise,” she said. “It felt like a violation of an unspoken norm.”

Hollywood's Open Secret

IN RECENT YEARS, MOUNJARO AND SIMILAR GLP-1 DRUGS like Wegovy, Ozempic and Zepbound have redefined how America thinks—and talks—about weight. What began as a diabetes treatment has become a billion-dollar industry fueled by off-label use, celebrity whispers and red-carpet transformations.

As the 2025 Hollywood awards season kicked off with the Golden Globes in January, so too did another round of jokes, speculation and sponsorships linking the industry to the use of GLP-1 medications for weight loss by A-list celebrities. Comedian Nikki Glaser, host of the Globes, dove right in at the start of her opening monologue: “Good evening, and welcome to the 82nd Golden Globes—Ozempic’s biggest night,” she began.

MORE STORIES FROM Newsweek Europe

Newsweek Europe

Newsweek Europe

Chasing Gratitude

Ultra-runner Hunter Leininger on how he keeps smiling through blisters and sickness on his extreme adventures

time to read

6 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

The Motor City Comeback

Outgoing Mayor Mike Duggan tells Newsweek how Detroit rebuilt pride and prosperity after bankruptcy—and why the city's resurgence is powered by its people

time to read

6 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Robin Wright

ROBIN WRIGHT KNEW THAT IN HER NEW PRIME VIDEO SHOW THE GIRL-friend—which she developed and is starring in—she would have to fight the potential for melodrama, because “it could easily go there.”

time to read

2 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Killer Instinct

THE KEY TO THURSDAY MURDER CLUB STAR HELEN MIRREN'S LONG AND STILL-FLOURISHING CAREER IS STANDING BY HER CHOICESWHICH HAVE LED HER TO OSCAR-, EMMY AND TONY-WINNING SUCCESS

time to read

8 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Mae Martin

FOR THEIR NEW SHOW WAYWARD, MAE MAR-tin “wanted a friendship at [its] heart.”

time to read

1 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

AMERICA'S MOST Admired WORKPLACES 2026

WHEN PEOPLE CONSIDER THEIR DREAM JOB, they often put companies they admire at the top of the list.

time to read

4 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Tiny Lives, Mighty Care

An exclusive look inside The Hospital for Sick Children, the world's top pediatric hospital

time to read

5 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

WORLD'S BEST SPECIALIZED HOSPITALS 2026

SPECIALIZED HOSPITALS ARE SEEING EXPLOSIVE growth as patients search for physicians that provide advanced, targeted care.

time to read

1 min

September 26, 2025

Newsweek Europe

Newsweek Europe

Monster Smash

KPop Demon Hunters' directors reveal what's next for Netflix's chart-topping film

time to read

5 mins

September 26, 2025

Newsweek Europe

Newsweek Europe

Heart and Soul Food

Chef Marcus Samuelsson on removing barriers to the industry and reshaping America's tastes

time to read

5 mins

September 26, 2025

Listen

Translate

Share

-
+

Change font size